Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Machin

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Lupus|February 10, 2011
Antiphospholipid Syndrome Clinical Research Task Force reportD Erkan, R Derksen, R Levy, et al.
Epidemiology and Infection|October 1, 1988
The haematological values of European badgers (Meles meles) in health and in the course of tuberculosis infectionK H Mahmood, J L Stanford, S Machin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 4, 2013
Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapyS Sabater, Ma M Sevillano, I Andres, et al.
British Journal of Rheumatology|November 24, 1998
Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndromeM Inanç, S Donohoe, C T Ravirajan, et al.
British Journal of Haematology|January 14, 1999
Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusionR Liesner, I Mackie, J Cookson, et al.
Thrombosis and Haemostasis|May 1, 1996
Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activityP A Charlton, R W Faint, F Bent, et al.
Lupus|September 18, 2014
Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodiesZ Romay-Penabad, A L Carrera Marin, R Willis, et al.
Cardiovascular Drugs and Therapy|October 1, 1995
Blockade of the human platelet GPIIb/IIIa receptor by a murine monoclonal antibody Fab fragment (7E3): potent dose-dependent inhibition of platelet functionS Bhattacharya, R Jordan, S Machin, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
The expression of prion protein (PrP(C)) in the megakaryocyte lineageR Starke, P Harrison, I Mackie, et al.
Lupus|February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodiesG Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Lupus|February 10, 2011
Antiphospholipid Syndrome Clinical Research Task Force reportD Erkan, R Derksen, R Levy, et al.
Epidemiology and Infection|October 1, 1988
The haematological values of European badgers (Meles meles) in health and in the course of tuberculosis infectionK H Mahmood, J L Stanford, S Machin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 4, 2013
Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapyS Sabater, Ma M Sevillano, I Andres, et al.
British Journal of Rheumatology|November 24, 1998
Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndromeM Inanç, S Donohoe, C T Ravirajan, et al.
British Journal of Haematology|January 14, 1999
Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusionR Liesner, I Mackie, J Cookson, et al.
Thrombosis and Haemostasis|May 1, 1996
Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activityP A Charlton, R W Faint, F Bent, et al.
Lupus|September 18, 2014
Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodiesZ Romay-Penabad, A L Carrera Marin, R Willis, et al.
Cardiovascular Drugs and Therapy|October 1, 1995
Blockade of the human platelet GPIIb/IIIa receptor by a murine monoclonal antibody Fab fragment (7E3): potent dose-dependent inhibition of platelet functionS Bhattacharya, R Jordan, S Machin, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
The expression of prion protein (PrP(C)) in the megakaryocyte lineageR Starke, P Harrison, I Mackie, et al.
Lupus|February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodiesG Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Pageof 5